Epigral Ltd Financials

Epigral Ltd Financial Statement

Epigral Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	631.03	649.10	631.61
Operating Expense	454.25	462.73	447.63
Net Profit	86.62	103.54	80.53
Net Profit Margin	13.73	15.95	12.75
Earning Per Share	20.08	24.23	19.38
EBIDTA	147.38	174.42	162.02
Effective Tax Rate	8.51	20.41	11.91

Particulars	Mar 2025
Revenue	631.03
Operating Expense	454.25
Net Profit	86.62
Net Profit Margin	13.73
Earning Per Share	20.08
EBIDTA	147.38
Effective Tax Rate	8.51

Epigral Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	1,929.19	2,188.40	1,550.94
Operating Expenses Annual	1,447.98	1,499.40	1,041.45
Operating Profit Annual	487.72	696.98	513.60
Interest Annual	73.49	65.50	44.27
Depreciation	123.56	108.95	85.91
Net Profit Annual	195.79	353.36	252.79
Tax Annual	94.88	169.17	130.64

Particulars	Mar 2024
Total Revenue Annual	1,929.19
Operating Expenses Annual	1,447.98
Operating Profit Annual	487.72
Interest Annual	73.49
Depreciation	123.56
Net Profit Annual	195.79
Tax Annual	94.88

Epigral Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	14.19	25.04	0.68
Cash Flow from Operations	397.69	626.16	283.82
Cash Flow from Investing	-401.10	-437.22	-454.68
Cash Flow from Financing	-7.60	-199.79	195.22
Cash Flow at the End	3.18	14.19	25.04

Particulars	Mar 2024
Cash Flow at the Beginning	14.19
Cash Flow from Operations	397.69
Cash Flow from Investing	-401.10
Cash Flow from Financing	-7.60
Cash Flow at the End	3.18

Epigral Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	25.28	31.85	33.12
PBIT Margin (%)	18.88	26.87	27.58
PBT Margin (%)	18.62	26.46	26.96
Net PROFIT Margin (%)	10.15	16.15	16.30
Return On Networth / Equity (%)	16.85	39.37	42.16
Return On Networth /Employed (%)	17.45	32.02	29.01
Return On Assets (%)	9.34	19.21	17.11
Total Debt / Equity (X)	0.67	0.73	0.81
Asset Turnover Ratio (%)	0.92	1.19	1.05

Particulars	Mar 2024
PBDIT Margin (%)	25.28
PBIT Margin (%)	18.88
PBT Margin (%)	18.62
Net PROFIT Margin (%)	10.15
Return On Networth / Equity (%)	16.85
Return On Networth /Employed (%)	17.45
Return On Assets (%)	9.34
Total Debt / Equity (X)	0.67
Asset Turnover Ratio (%)	0.92

Epigral Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	1,766.64	1,804.05	1,067.83
Total Current Assets Annual	501.93	419.45	446.89
Non Current Assets Annual	2,292.40	2,012.80	1,676.77
Total Shareholders Funds Annual	1,254.09	1,069.17	725.97
Total Assets Annual	2,794.33	2,432.25	2,123.67

Particulars	Mar 2024
Fixed Assets Annual	1,766.64
Total Current Assets Annual	501.93
Non Current Assets Annual	2,292.40
Total Shareholders Funds Annual	1,254.09
Total Assets Annual	2,794.33

Epigral Ltd Earning Calls

EPS (INR)

Expected

20.14

Reported

20.14

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.96%

Jun 2024

EPS beaten by 0.00%

Dividend Pages

PE Ratio

FAQS on Epigral Ltd Financials

As of May 9, 2025, Epigral Ltd has a market capitalization of 8,191.68 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Epigral Ltd is debt-free with a debt-to-equity ratio of 0.31.

In FY 2024 , Epigral Ltd recorded a total revenue of approximately 2,550.13 Cr marking a significant milestone in the company's financial performance.

Epigral Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Epigral Ltd's current PE ratio is 22.97.

Epigral Ltd's ROCE averaged 23.4% from the FY ending March 2023 to 2025, with a median of 23.7%. It peaked at 30.2% in March 2023, reflecting strong capital efficiency over the period..

Epigral Ltd's latest EBIT is Rs. 593.37 Cr, surpassing the average EBIT of Rs. 515.19 Cr over the 5 years..